Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Osteoporosis International
Published in: Osteoporosis International 5/2010

Open Access 01-05-2010 | Original Article

A pilot case–control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw

Authors: Y. Takaishi, T. Ikeo, M. Nakajima, T. Miki, T. Fujita

Published in: Osteoporosis International | Issue 5/2010

Login to get access

Abstract

Summary

Alveolar bone mineral density (BMD) measured by radiography standardized by aluminum step wedge pasted on the film and digitized by a computer system was significantly higher around osteonecrosis lesions than in control cases in a pilot case–control study. High alveolar bone density appears useful as a local risk factor for bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Introduction

In an attempt to find a reliable test method predicting the occurrence of BRONJ in addition to various risk factors suggested, an increase of alveolar bone density near the necrotic lesions was found by computerized radiogrammetry using dental films pasted with an aluminum step wedge (Bone RightⓇ, Dentalgraphic⋅Com Company, Himeji) in six cases of BRONJ.

Methods

The bone mineral density surrounding the osteonecrosis lesions showed distinctly higher density in BRONJ cases compared with age-matched controls. In one subject on bisphosphonate treatment in whom two extractions were simultaneously carried out, BRONJ occurred only at the location with extremely high alveolar bone density, but not at the other site with normal density.

Conclusion

This method may be useful in detecting a rise of alveolar BMD frequently occurring near the necrotic lesion in subjects with impending risk for BRONJ.
Literature
1.
Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 61:1115–1117CrossRefPubMed
2.
Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws (2007) Position paper of the American Association of Oral and Maxillofacial Surgeons on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg 65:369–376CrossRef
3.
Editorial (2007) Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 22:1479–1490CrossRef
4.
Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P (2007) Osteoporosis in the jaw of patients who are using oral bisphosphonates to treat osteoporosis. Int J Oral Maxillofac Implants 22:146–153
5.
Bamias A, Kastritis E, Bamias C (2006) Osteonecrosis of the jaw in cancer after treatment with bisphosphonates : incidence and risk factors. J Oral Maxillofac Surg 64:995–996
6.
Pazianas M, Miller P, Blumental WA, Bernal M, Kothawala P (2007) A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates : prevalence, risk factors, and clinical characteristics. Clin Therapeut 29:1548–1558CrossRef
7.
Cartsos VM, Zhu S, Zavras AI (2008) Bisphosphonate use and the risk of adverse jaw outcomes. A medical claims study of 714, 217 people. J Am Dent Ass 139:23–30PubMed
8.
Marx RE, Cillo JE Jr, Ulloa JJ (2007) Oral bisphosphonate-induced osteonecrosis: risk factors. Prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg 65:2377–410
9.
Takaishi Y, Ikeo T, Miki T, Nishizawa Y, Morii H (2003) Suppression of alveolar bone resorption by periodontal disease : 4 to 5 year follow-up of 4 patients. J Int Med Res 31:575–584PubMed
10.
Takaishi Y, Ikeo T, Miki T, Morii H (2005) Correlations between periodontitis and loss of mandibular bone in relation to systemic bone changes in postmenopausal Japanese women. Osteopor Int 16:1875–1882CrossRef
Metadata
Title
A pilot case–control study on the alveolar bone density measurement in risk assessment for bisphosphonate-related osteonecrosis of the jaw
Authors
Y. Takaishi
T. Ikeo
M. Nakajima
T. Miki
T. Fujita
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Osteoporosis International / Issue 5/2010
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-009-1021-z

Other articles of this Issue 5/2010

Osteoporosis International 5/2010 Go to the issue

Original Article

Women with hip fracture experience greater loss of geometric strength in the contralateral hip during the year following fracture than age-matched controls

Original Article

Estimation of serum osteocalcin and telopeptide-C in postmenopausal osteoporotic females

Original Article

Preference and satisfaction with a 6-month subcutaneous injection versus a weekly tablet for treatment of low bone mass

Original Article

Prognosis of fracture: evaluation of predictive accuracy of the FRAX™ algorithm and Garvan nomogram

Erratum

Erratum to: No association between polymorphisms of peroxisome proliferator-activated receptor-gamma gene and peak bone mineral density variation in Chinese nuclear families

Original Article

Fracture incidence in nursing homes in Japan